Russian Heart Failure Journal 2011year Etiologic causes of CHF development in the European part of the Russian Federation (hospital stage)


To access this material please log in or register

Register Authorize
2011/

Etiologic causes of CHF development in the European part of the Russian Federation (hospital stage)

Belenkov Yu. N., Mareev V. Yu., Ageev F. T., Fomin I. V., Badin Yu. V., Poliakov D. S., Danielian M. O., Artemieva E. G., Malenkova V. Yu., Poroshina E. A., Smirnova E. A., Tarlovskaya E. K., Scherbinina E. V., Yakushin S. S.

Keywords: CHF, etiology

DOI: 10.18087/ rhfj.2011.6.1589

Relevance. In the main epidemiological studies carried out before 1990‑s, AH and CHD were studied as competing etiological factors of CHF. Later CHD and cardiomyopathies became such. Purpose. The analysis of CHF development reasons in patients, enrolled to the epidemiological study EPOCH at the outpatient stage, with the subsequent specification of CHF diagnosis after hospitalisation. Materials and methods. In 2002, representative sampling of residents of the European part of the Russian Federation, including 19,503 respondents, was made. The patients with provisional diagnosis of I–IV class CHF formed the group of respondents. From 2003 to 2005, within the hospital research in four regions of the European part of the Russian Federation (Nizhniy Novgorod, Ryazan, and Kirov Regions and Chuvash republic) 931 respondents (80.7 % of total number of subjects) with provisional diagnosis of CHF were hospitalized. Results. The true frequency rate of CHF of any class in the European part of the Russian Federation made up 7 %, distribution of patients with CHF by the functional classes was the following: functional class I – 22.7 %, class II – 47.4 %; class III – 25.1 % and class IV – 4.7 %. AH and CHD (stable stenocardia) were established to be the principal causes CHF in the Russian Federation population. In patients with IV class CHF, the basic etiological factors are the following: old severe MI, inadequately corrected heart disease, dilated cardiomyopathy, severe DM and constant form atrial fibrillation. More severe progression of CHF is caused by complex of CHD, AH, DM, old MI and ACVA.
  1. Ho KK, Anderson KM, Kannel WB et al. Survival after the onset of congestive heart faliure in Framingham Heart Study subjects. Circulation. 1993;88 (1):107–115.
  2. Landahl S, Svanborg A, Astrand K. Heart volume and the prevalence of certain common cardiovascular disorders at 70 and 75 years of age. Eur Heart J. 1984;5 (4):326–331.
  3. Kannel W. Epidemiology and prevention of cardiac failure: Framingham Study insights. Eur Heart J 1987;8 (Suppl F):23–29.
  4. Katz AM. Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure. N Engl J Med. 1990;322 (2):100–110.
  5. Killip T. Epidemiology of congestive heart failure. Am J Cardiol. 1985;56 (2):2A-6A.
  6. Manolio TA, Baughman KL, Rodeheffer R et al. Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop). Am J Cardiol. 1992;69 (17):1458–1466.
  7. Bigger JT Jr. Why patients with congestive heart failure die: arhythmias and sudden cardiac death. Circulation. 1987;75 (5 Pt 2):IV28–35.
  8. Kannel WB, Plehn JF, Cupples LA. Cardiac failure and sudden death in the Framingham Study. Am Heart J. 1988;115 (4):869–875.
  9. Teerlink JR, Goldhaber SZ, Pfeffer MA. An overview of contemporary etiologies of congestive heart failure. Am Heart J. 1991;121 (6 Pt 1):1852–1853.
  10. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol. 1974;34 (1):29–34.
  11. Cohn JN, Archibald DG, Ziesche S et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med. 1986;314 (24):1547–1552.
  12. Cohn JN. Prognostic factors in heart failure: poverty amidst a wealth of variables. J Am Coll Cardiol. 1989;14:571–572.
  13. Harlan WR, Oberman A, Grimm R, Rosati RA. Chronic congestive heart failure in coronary artery disease: clinical criteria. Ann Intern Med. 1977;86 (2):133–138.
  14. Stevenson R, Ranjadayalan K, Wilkinson P et al. Short and long term prognosis of acute myocardial infarction since introduction of thrombolysis. BMJ. 1993;307 (6900):349–353.
  15. Mosterd A, Hoes AW, de Bruyne MC et al. Prevalence of heart failure and left ventricular dysfunction in the general population. The Rotterdam Study. Eur Heart J. 1999;20 (6):447–455.
  16. Cleland J, Swedberg K, Follath F et al. The IMPROVEMENT of heart fa­ilure survey. International variations in the aetiology of heart failure managed in primary care. Eur J Heart Fait. 2001; 3: S72. [Abstract].
  17. McMurray JJ, Stewart S. Epidemiology, actiology and prognosis of heart failure. Heart. 2000;83 (5):596–602.
  18. Отрохова Е. В., Мареев В. Ю. Эпидемиологические и этиологические особенности больных сердечной недостаточностью в Смоленском регионе. Журнал Сердечная недостаточность. 2007;8 (2):69–75.
  19. Sharpe N, Doughty R. Epidemiology of heart failure and ventricular dysfunction. Lancet. 1998;352 (Suppl 1):3–8.
  20. Kannel WB, Ho K, Thorn T. Changing epidemiological feattres of cardiac failure. Br Heart J. 1994;72 (2 Suppl):S3–9.
  21. Kannel WB, Castelli WP, McNamara PM et al. Role of blood pressure in the development of congestive heart failure. The Framingham Study. N Engl J Med. 1972;287 (16):781–787.
  22. Yusuf S, Thom T, Abbott RD. Changes in hypertension treatment and in congestive heart failure mortality in the United States. Hypertension. 1989;13 (5 Suppl):I74–79.
  23. Мареев В. Ю., Беленков Ю. Н., Агеев Ф. Т. и др. Первые результаты Российского эпидемиологического исследования по ХСН (ЭПОХА–ХСН). Журнал Сердечная Недостаточность 2003; 4 (1):17–18.
  24. Epstein FH, Ostrander LD, Johnson ВС et al. Epidemiological studies of cardiovascular disease in a total community – Tecumseh, Michigan. Ann Intern Med. 1965;62:1170–1187.
  25. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 1971;285 (26):1441–1446.
  26. Kannel WB, Belanger AJ. Epidemiology of heart failure. Am Heart J. 1991;121 (3 Pt 1):951–957.
  27. Lamberts H, Brouwer HJ, Mohrs J. Reason for encounter – and episode and process oriented standard output from the Transition Project. Part 1&2. Amsterdam: Dept. of General Practice, 1993.
  28. Cleland JGF, Swedberg K, Follath F et al. The EuroHeart Failure Survey programme – a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J. 2003;24 (5):442–463.
  29. Komajda M, Follath F, Swedberg K et al. The EuroHeart Failure Survey programme – a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment Eur. Heart J. 2003;24 (5):464–474.
Belenkov Yu.N., Mareev V.Yu., Ageev F.T. et al. Etiologic causes of CHF development in the European part of the Russian Federation (hospital stage). Russian Heart Failure Journal. 2011;12(6):333-338.

To access this material please log in or register

Register Authorize
Ru En